Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
CELLULAR IMMUNOLOGY, ANTIBODIES, AND MEDIATORS OF IMMUNITY

The Gamma Interferon (IFN-γ) Mimetic Peptide IFN-γ(95-133) Prevents Encephalomyocarditis Virus Infection both in Tissue Culture and in Mice

Mustafa G. Mujtaba, Chintak B. Patel, Ravi A. Patel, Lawrence O. Flowers, Marjorie A. Burkhart, Lilian W. Waiboci, James Martin, Mohammad I. Haider, Chulbul M. Ahmed, Howard M. Johnson
Mustafa G. Mujtaba
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
2Department of Physical Sciences and Mathematics, Florida Gulf Coast University, Fort Myers, Florida 33965
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mmujtaba@fgcu.edu
Chintak B. Patel
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravi A. Patel
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence O. Flowers
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjorie A. Burkhart
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lilian W. Waiboci
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Martin
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad I. Haider
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chulbul M. Ahmed
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard M. Johnson
1Department of Microbiology and Cell Science, University of Florida, Gainesville, Florida 32611
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00021-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    IFN-γ mimetics possess antiviral activity against EMC virus in tissue culture. Mouse L929 cells were plated and grown to confluence on a 96-well plate. Various concentrations of mouse IFN-γ (300 U/ml to 11 U/ml) and various concentrations of IFN-γ(95-133), IFN-γ(95-133)SV40, SV40, IFN-γ(126-133), and IFN-γ(95-125) peptides, ranging from 100 μM to 3.7 μM, were incubated with L929 cells for 7 h, after which EMC virus (EMCV) (2,000 PFU/ml) was added. After 1 h, virus was removed and media added to all wells, followed by incubation for at least 28 h. Cells were stained with crystal violet solution, and plates were scanned and analyzed to assess cell survival. (A) Digital image of the plate. (B) Image J 1.29 software was used to analyze the image to obtain gray value to assess cell survival, presented here as percentages of the medium control value (100% cell survival). Representative data from one of three experiments are presented. Error bars indicate standard errors of the means.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Cellular toxicity of IFN-γ(95-133), derivatives, and control peptides. Mouse L929 cells were plated and grown to confluence on a 96-well plate. Various concentrations of IFN-γ(95-133), IFN-γ(95-133)SV40, SV40, IFN-γ(126-133), and IFN-γ(95-125) peptides, ranging from 100 μM to 3.7 μM, were incubated with L929 cells for 35 h. Cells were stained with crystal violet solution, and plates were scanned and analyzed to assess cell survival. (A) Digital image of the plate. (B) Image J 1.29 software was used to analyze the image to obtain gray value to assess cell survival, presented here as percentages of the medium control value (100% cell survival). Representative data from one of three experiments are presented. Error bars indicate standard errors of the means.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Protection of mice from EMC virus infection by IFN-γ and the IFN-γ mimetic peptide IFN-γ(95-133) is dose dependent. (A) C57BL/6 mice (10 mice per treatment group) were pretreated by intraperitoneal injection for 6 days with PBS, IFN-γ(95-125) and IFN-γ(95-133) peptides (100 μg/day), or IFN-γ (3,000 U/day). (B) Mice (five mice per treatment group) were pretreated with 200 μg/day of either IFN-γ(95-133) or IFN-γ(95-125) peptide for 3 days. On the last day of treatment, mice were challenged by intraperitoneal injection with 50 PFU of EMC virus. The numbers of surviving mice were recorded starting on the day of EMC virus challenge (day 0) and are presented as percent survival. Representative data from one of two experiments are shown.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Mice treated with IFN-γ(95-133) peptide have reduced or no EMC virus particles in sera and various tissues. C57BL/6 mice were pretreated for 3 days with IFN-γ (3,000 U/day), IFN-γ(95-133) (200 μg/day), or the control peptide IFN-γ(95-125) (200 μg/day). On the last day of treatment, mice were challenged with 50 PFU of EMC virus. On day 6 after EMC virus infection, mice were bled and sacrificed, after which equal amounts of heart, spleen, and liver tissues were extracted from each group, homogenized, and lysed by thawing/freezing. (A to D) Samples were centrifuged, and supernatants were diluted and incubated on murine L929 cells plated to confluence in a 96-well plate for detection of EMC virus cytopathic effect after being stained with crystal violet solution. (E) Sera from various treatment groups were diluted and incubated with L929 cells as described above for determination of cytopathic effect. Tissues and sera from three mice per treatment group were analyzed, and representative data from one of two experiments are shown.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    B8R neutralizes IFN-γ but not IFN-γ(95-133) antiviral activity. Murine L929 cells were plated to confluence, after which media and various concentrations of IFN-γ, IFN-γ(95-133), and IFN-γ(95-125) that were preincubated for 2 h with or without B8R (33 μg/ml) were added to the plate. After 24 h of incubation, EMC virus (EMCV) (200 PFU/ml) was added for 1 h of incubation and washed with media. Cells were then incubated with media for 24 h, after which wells were stained with crystal violet and washed. (A) Digital image of the plate. (B) The plate was scanned for cell viability assessment using Image J software (NIH). Percent cell viability is presented for 33 U/ml of IFN-γ and 11 μM of IFN-γ(95-133). Error bars indicate standard errors of the means.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Protection of mice from EMC virus challenge by the IFN-γ(95-133) peptide in the presence of B8R protein. C57BL/6 mice were pretreated for 3 days with PBS, IFN-γ(95-133) (100 μg/day), or rat IFN-γ (200 U/day) in the presence or absence of the B8R protein (25 μg). On the last day of treatment, mice were challenged with 50 PFU of EMC virus. The numbers of surviving mice were recorded starting on the day of EMC virus challenge (day 0) and are presented as percent survival. Ten mice per treatment group were used, and representative data from one of two experiments are shown.

Tables

  • Figures
  • TABLE 1.

    Sequences of murine IFN-γ(95-133), derivatives, and control peptidesa

    PeptideSequence
    IFN-γ(95-133)AKFEVNNPQVQRQAFNELIRVVHQLLPESSLRKRKRSRC
    IFN-γ(95-125)AKFEVNNPQVQRQAFNELIRVVHQLLPESSL
    IFN-γ(95-133)SV40AKFEVNNPQVQRQAFNELIRVVHQLLPESSLPKKKRKV
    SV40 T antigenPKKKRKV
    IFN-γ(126-133)RKRKRSRC
    IFNGR(253-287)TKKNSFKRKSIMLPKSLLSVVKSATLETKPESKYS
    • ↵ a Peptides were synthesized as described in Materials and Methods. The NLS (RKRKRSR) of IFN-γ(95-133) and the NLS (PKKKRKV) of IFN-γ(95-133)SV40 are highlighted in boldface type.

  • TABLE 2.

    IFN-γ and IFN-γ(95-133) reduction of EMC virus yielda

    TreatmentConcnVirus yield (PFU/ml)Fold reduction
    Medium only4.1 × 108
    IFN-γ2,500 U/ml1.1 × 10737.3
    IFN-γ(95-133)20 μM1.7 × 10724.1
    IFNGR(253-287)20 μM6.3 × 1080.7
    • ↵ a Mouse L929 fibroblasts seeded to confluence in a 25-cm2 flask were pretreated with 2,500 U/ml of IFN-γ, 20 μM of IFN-γ(95-133), or 20 μM of IFNGR(253-287) control peptide for 24 h, after which cells were challenged with EMC virus at 100 PFU/ml for 1 h. Flasks were washed and incubated with media for another 24 h. Virus produced was harvested and titrated by a standard viral plaque assay (see Materials and Methods). The numbers of PFU/ml of the original samples were reported and reduction (n-fold) calculated via dividing the number of PFU/ml of the medium-only control by the number of PFU/ml of each experimental sample.

  • TABLE 3.

    Induction of EMC virus infection in C57BL/6 micea

    Treatment% Survival at the indicated day after EMC virus infection
    045678
    Medium10010050502525
    IFN-γ100100100755050
    IFN-γ(95-133)100100100100100100
    • ↵ a Mouse L929 fibroblasts were treated with media, 2.5 × 103 U/ml of IFN-γ, or 20 μM of IFN-γ(95-133) for 24 h, after which cells were incubated with 100 PFU/ml of EMC virus for 1 h. Cells were then washed three times with media to wash away residual IFN-γ and peptides from the cells. Cells were resuspended with media for 24 h and supernatants collected. All supernatants were diluted with media (1:200,000) prior to intraperitoneal injection of mice on day 0. Mortality from EMC virus infection was recorded, and the percentage of surviving mice for each treatment group is presented. No change was seen in the mice after the eighth day postinjection with supernatants. A total of eight mice per group were used.

PreviousNext
Back to top
Download PDF
Citation Tools
The Gamma Interferon (IFN-γ) Mimetic Peptide IFN-γ(95-133) Prevents Encephalomyocarditis Virus Infection both in Tissue Culture and in Mice
Mustafa G. Mujtaba, Chintak B. Patel, Ravi A. Patel, Lawrence O. Flowers, Marjorie A. Burkhart, Lilian W. Waiboci, James Martin, Mohammad I. Haider, Chulbul M. Ahmed, Howard M. Johnson
Clinical and Vaccine Immunology Aug 2006, 13 (8) 944-952; DOI: 10.1128/CVI.00021-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Gamma Interferon (IFN-γ) Mimetic Peptide IFN-γ(95-133) Prevents Encephalomyocarditis Virus Infection both in Tissue Culture and in Mice
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Gamma Interferon (IFN-γ) Mimetic Peptide IFN-γ(95-133) Prevents Encephalomyocarditis Virus Infection both in Tissue Culture and in Mice
Mustafa G. Mujtaba, Chintak B. Patel, Ravi A. Patel, Lawrence O. Flowers, Marjorie A. Burkhart, Lilian W. Waiboci, James Martin, Mohammad I. Haider, Chulbul M. Ahmed, Howard M. Johnson
Clinical and Vaccine Immunology Aug 2006, 13 (8) 944-952; DOI: 10.1128/CVI.00021-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cardiovirus Infections
Encephalomyocarditis virus
Interferon-gamma
Peptide Fragments
Peptides

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X